One of the problems with people who are dealing with a chronic cardiovascular disease is reminding them to take their medication regularly and at the time and in the manner recommended by their doctor. Cardiovascular Business has a story about a study conducted by Montefiore Medical Center in the Bronx, New York that explored a new way to ensure medication compliance.
The study consisted of 28 people who had had an ischemic stroke and had been prescribed warfarin, dabigatran, rivaroxaban or apixaban. Fifteen of the patients were randomly selected to be monitored daily by an AI app on a smartphone that has been developed by AICure, while a control group had no such monitoring.
The AI apps, customized for each patient, would gently remind them when it was time to take their medication with instructions on how and in what doses. If the patient missed the dosage window by an hour, a text message was automatically sent to a clinic.
At the end of the 12 weeks, the compliance percentage for the people with the AI app was 97.2 percent as opposed to 90.6 percent for the control group. The difference based on blood tests was even starker, 100 percent for those patients with the AI app versus 50 percent for the control group.
The patients who were given the AI app were asked to rate the system before and after the tests. Before using it, 73.3 percent and after using it, 83.3 percent rated the app as “extremely good” as a tool to manage their medication and for promoting a good doctor-patient relationship.
Our strategy focuses on enabling our clients to recruit the right people for the structure in which they will perform. Please contact us to learn more about our expertise in Executive Search for Commercial Leadership positions in Medical Device and Biotechnology; including Marketing, Strategy, Sales Leadership, Training, Development, etc. We look forward to the opportunity to help you consistently improve your performance and your business!
Follow me on Twitter @PrimeCoreSearch.